SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25

SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25 Share Price

DE000SW7K5H5

Real-time Boerse Frankfurt Warrants 08:51:09 23/05/2024 BST
2.55 ^EUR	-4.49%

Current month	+89.36%
1 month	+181.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/21.03.25

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	05-22	AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	05-21	AQ
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	05-17	MT

More news

Quotes 5-day view

Date	Price	Change
23/05/24	2.55	-4.49%
22/05/24	2.67	+8.10%
21/05/24	2.47	-1.59%
20/05/24	2.51	+10.09%
17/05/24	2.28	-0.44%

Real-time Boerse Frankfurt Warrants

Last update May 23, 2024 at 08:51 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Société Générale
WKN	SW7K5H
ISIN	DE000SW7K5H5
Date issued	12/03/2024
Strike	17 $
Maturity	21/03/2025 (303 Days)
Parity	1 : 1
Emission price	1.28 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	2.75 €
Lowest since issue	0.78 €
Delta	0.62x
Omega	3.543
Premium	18.11x
Gearing	5.75x
Moneyness	0.9929
Difference Strike	0.12 $
Difference Strike %	+0.71%
Spread	0.24 €
Spread %	8.48%
Theoretical value	2.705
Implied Volatility	43.52 %
Total Loss Probability	53.96 %
Intrinsic value	0.000000
Present value	2.705
Break even	19.93 €
Theta	-0.03x
Vega	0.05x
Rho	0.06x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company